Insider · CIK 0001534338
Bessemer Venture Partners VII L.P.
Files at GUTS (Fractyl Health, Inc.). First filing -, latest -.
In brief
Bessemer Venture Partners VII L.P. files SEC Form 4 as 10% owner at GUTS (Fractyl Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bessemer Venture Partners VII L.P. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 2, 2026 | FVRR Fiverr International Ltd. | 179,652 0.50% of outstanding | $2.1M | Jun 2, 2026 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | GUTS Fractyl Health, Inc. | CConversion Common Stockindirect: See footnotes | +4,770,901 | - | - | 4,770,901 | Feb 8, 2024 |
| Feb 6, 2024 | GUTS Fractyl Health, Inc. | CConversion Series A Preferred Stockderivativeindirect: See footnotes | -1,953,271 | - | - | 0 | Feb 8, 2024 |
| Feb 6, 2024 | GUTS Fractyl Health, Inc. | CConversion Series B Preferred Stockderivativeindirect: See footnotes | -3,161,709 | - | - | 0 | Feb 8, 2024 |
| Feb 6, 2024 | GUTS Fractyl Health, Inc. | CConversion Series C-1 Preferred Stockderivativeindirect: See footnotes | -2,236,537 | - | - | 0 | Feb 8, 2024 |
| Feb 6, 2024 | GUTS Fractyl Health, Inc. | CConversion Series C-2 Preferred Stockderivativeindirect: See footnotes | -1,625,698 | - | - | 0 | Feb 8, 2024 |
| Feb 6, 2024 | GUTS Fractyl Health, Inc. | CConversion Series D Preferred Stockderivativeindirect: See footnotes | -908,998 | - | - | 0 | Feb 8, 2024 |
| Feb 6, 2024 | GUTS Fractyl Health, Inc. | CConversion Series E Preferred Stockderivativeindirect: See footnotes | -352,159 | - | - | 0 | Feb 8, 2024 |
Questions about Bessemer Venture Partners VII L.P.
Answered from the filings on this page, as of the latest one.
Is Bessemer Venture Partners VII L.P. buying or selling?
Bessemer Venture Partners VII L.P. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bessemer Venture Partners VII L.P.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bessemer Venture Partners VII L.P. has 0.
Where does Bessemer Venture Partners VII L.P. file Form 4?
Bessemer Venture Partners VII L.P. has filed Form 4 at GUTS (Fractyl Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.